Dissecting the means by which type 3 substrates are defined & secreted

剖析 3 类底物的定义方式

基本信息

  • 批准号:
    10589974
  • 负责人:
  • 金额:
    $ 3.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-02-01 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

The virulence of many human bacterial pathogens is dependent on transkingdom nanomachines, including type III secretion systems (T3SSs), which act to directly deliver tens of virulence proteins, often referred to as effectors, into the cytosol of mammalian cells. Many critical gaps exist in our understanding of how type III secreted (T3S) proteins, referred to as effectors, are defined and delivered to the T3S apparatus (T3SA). While each pathogen injects its own unique set of effectors into hosts, components of their machines share a high degree of similarity. For several decades, the dogma has been that the effector secretion is dependent on small acidic T3S chaperones that bind to their N-terminal regions. These chaperones control the hierarchy of secretion of proteins by mediating their recruitment to the sorting platform, a complex that cycles between the cytosol and membrane-embedded T3SA. Interestingly, cognate chaperones have not yet been identified for the majority of T3S effectors, including those from intensively studied Salmonella, Yersinia, Shigella and pathogenic Escherichia T3SSs. Here, we present data that support the existence of a noncanonical T3SS chaperone-independent (CI) pathway likely conserved across numerous phylogenetically distinct T3SS families. Here, using the Shigella flexneri T3SS as a model system, we propose to: 1. Determine how T3S chaperones are recruited to the sorting platform. Using the Protein Interaction 2. Dissect the molecular mechanisms by which CI effectors are recognized and delivered to the T3SA. 3. Investigate the existence of a co-translational ATPase-independent type III secretion pathway. Together the proposed studies shown not only advance our understanding regarding how T3S effectors are defined and delivered to the T3SA, but also result in the identification of targets for the development of novel antimicrobial agents that target the virulence of the large family of Gram-negative bacterial pathogens whose virulence is dependent on a functional T3SS.
许多人类细菌病原体的毒力依赖于跨界纳米机器,包括 III 型分泌系统 (T3SS),可直接传递数十种毒力蛋白,通常称为 效应器进入哺乳动物细胞的细胞质。我们对 III 型如何理解存在许多关键差距 分泌型 (T3S) 蛋白(称为效应器)被定义并递送至 T3S 装置 (T3SA)。尽管 每种病原体将其独特的一组效应器注入宿主,其机器的组件共享高 相似程度。几十年来,人们一直认为效应器的分泌取决于 与其 N 末端区域结合的小型酸性 T3S 伴侣。这些伴侣控制着等级制度 通过介导蛋白质被招募到分选平台来分泌蛋白质,分选平台是一个在蛋白质之间循环的复合体 胞浆和膜嵌入的 T3SA。有趣的是,尚未确定同源伴侣 大多数 T3S 效应子,包括来自深入研究的沙门氏菌、耶尔森氏菌、志贺氏菌和 致病性大肠杆菌 T3SS。在这里,我们提供支持非规范 T3SS 存在的数据 分子伴侣独立(CI)途径可能在许多系统发育上不同的 T3SS 中保守 家庭。在这里,使用福氏志贺菌 T3SS 作为模型系统,我们建议: 1. 确定如何将 T3S 伴侣招募到分拣平台。利用蛋白质相互作用 2. 剖析 CI 效应子被识别并传递至 T3SA 的分子机制。 3. 研究共翻译 ATP 酶独立的 III 型分泌途径的存在。 总之,拟议的研究不仅增进了我们对 T3S 效应器如何发挥作用的理解 定义并交付给 T3SA,还确定了开发新型药物的目标 针对革兰氏阴性细菌病原体大家族的毒力的抗菌剂 毒力取决于功能性 T3SS。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CAMMIE LESSER其他文献

CAMMIE LESSER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CAMMIE LESSER', 18)}}的其他基金

Shigella mediated regulation of epithelial cell inflammasomes
志贺氏菌介导的上皮细胞炎症小体的调节
  • 批准号:
    10608342
  • 财政年份:
    2023
  • 资助金额:
    $ 3.13万
  • 项目类别:
Designer EcN for treatment of solid tumors
用于治疗实体瘤的 Designer EcN
  • 批准号:
    10459848
  • 财政年份:
    2022
  • 资助金额:
    $ 3.13万
  • 项目类别:
Designer EcN for treatment of solid tumors
用于治疗实体瘤的 Designer EcN
  • 批准号:
    10565935
  • 财政年份:
    2022
  • 资助金额:
    $ 3.13万
  • 项目类别:
Designer probiotics for prevention of cholera
用于预防霍乱的设计师益生菌
  • 批准号:
    9896226
  • 财政年份:
    2020
  • 资助金额:
    $ 3.13万
  • 项目类别:
Designer probiotics for prevention of cholera
用于预防霍乱的设计师益生菌
  • 批准号:
    10092926
  • 财政年份:
    2020
  • 资助金额:
    $ 3.13万
  • 项目类别:
Dissecting the means by which type 3 substrates are defined & secreted
剖析 3 类底物的定义方式
  • 批准号:
    10328544
  • 财政年份:
    2019
  • 资助金额:
    $ 3.13万
  • 项目类别:
Dissecting the means by which type 3 substrates are defined & secreted
剖析 3 类底物的定义方式
  • 批准号:
    10274790
  • 财政年份:
    2019
  • 资助金额:
    $ 3.13万
  • 项目类别:
Dissecting the means by which type 3 substrates are defined & secreted
剖析 3 类底物的定义方式
  • 批准号:
    10411510
  • 财政年份:
    2019
  • 资助金额:
    $ 3.13万
  • 项目类别:
Dissecting the means by which type 3 substrates are defined & secreted
剖析 3 类底物的定义方式
  • 批准号:
    10553659
  • 财政年份:
    2019
  • 资助金额:
    $ 3.13万
  • 项目类别:
PIPs: a new means to identify effector-target interactions
PIP:识别效应器-目标相互作用的新方法
  • 批准号:
    8777643
  • 财政年份:
    2014
  • 资助金额:
    $ 3.13万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 3.13万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.13万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 3.13万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.13万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 3.13万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 3.13万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.13万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 3.13万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 3.13万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.13万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了